{"id":1014808,"date":"2026-10-28T17:19:30","date_gmt":"2026-10-28T21:19:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/"},"modified":"2026-10-28T17:19:30","modified_gmt":"2026-10-28T21:19:30","slug":"mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/","title":{"rendered":"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026"},"content":{"rendered":"
\n

RADNOR, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the third quarter ended September 30, 2026, after the financial markets close on Wednesday, November 4, 2026.<\/p>\n\n\n\n\n\n\n
\n
\n
\n Wednesday, November 4<\/u>
\n <\/em>
\n <\/strong>
\n
\n
\n
\n th<\/u>
\n <\/em>
\n <\/strong>
\n <\/sup>
\n
\n
\n @ 4:30 p.m. ET<\/u>
\n <\/em>
\n <\/strong>\n <\/td>\n<\/tr>\n
Domestic:<\/td>\n1-877-704-4453<\/td>\n<\/tr>\n
International:<\/td>\n1-201-389-0920<\/td>\n<\/tr>\n
Conference ID:<\/td>\n13762560<\/td>\n<\/tr>\n
Webcast:<\/td>\n\n Link<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n
A live webcast of the conference call may also be found on the \u201cNews & Events<\/a>\u201d page in the Investors section of the Mineralys Therapeutics website.<\/p>\n

\n About\u00a0Mineralys<\/strong>
\n
Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is an investigational, proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit\u00a0https:\/\/mineralystx.com<\/a>. Follow Mineralys on\u00a0LinkedIn<\/a>,\u00a0X<\/a>\u00a0and\u00a0Bluesky<\/a>.<\/p>\n

\n Contact:<\/strong>\n <\/p>\n

\n Investor Relations<\/strong>
\n
\n investorrelations@mineralystx.com<\/a>\n <\/p>\n

\n Media Relations<\/strong>
\n
Melyssa Weible
Elixir Health Public Relations
Email:\u00a0mweible@elixirhealthpr.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

RADNOR, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the third quarter ended September 30, 2026, after the financial markets close on Wednesday, November 4, 2026. Wednesday, November 4 th @ 4:30 p.m. ET Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13762560 Webcast: Link A live webcast of the conference call may also be found on the \u201cNews & Events\u201d page in the Investors section of the Mineralys Therapeutics website. About\u00a0Mineralys Mineralys Therapeutics is a biopharmaceutical company … <\/p>\n

Continue reading “Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1014808","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the third quarter ended September 30, 2026, after the financial markets close on Wednesday, November 4, 2026. Wednesday, November 4 th @ 4:30 p.m. ET Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13762560 Webcast: Link A live webcast of the conference call may also be found on the \u201cNews & Events\u201d page in the Investors section of the Mineralys Therapeutics website. About\u00a0Mineralys Mineralys Therapeutics is a biopharmaceutical company … Continue reading "Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-28T21:19:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026\",\"datePublished\":\"2026-10-28T21:19:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/\"},\"wordCount\":215,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/\",\"name\":\"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==\",\"datePublished\":\"2026-10-28T21:19:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/","og_locale":"en_US","og_type":"article","og_title":"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - Market Newsdesk","og_description":"RADNOR, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the third quarter ended September 30, 2026, after the financial markets close on Wednesday, November 4, 2026. Wednesday, November 4 th @ 4:30 p.m. ET Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13762560 Webcast: Link A live webcast of the conference call may also be found on the \u201cNews & Events\u201d page in the Investors section of the Mineralys Therapeutics website. About\u00a0Mineralys Mineralys Therapeutics is a biopharmaceutical company … Continue reading \"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-28T21:19:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026","datePublished":"2026-10-28T21:19:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/"},"wordCount":215,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/","name":"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==","datePublished":"2026-10-28T21:19:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDg0MiM3OTIwNjQ4IzUwMDExMzcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-host-conference-call-on-wednesday-november-4-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1014808"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014808\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1014808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1014808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1014808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}